This podcast is brought to you by:

Diana Brainard, M.D.



August 4, 2021

Dr. Diana Brainard of AlloVir, discusses her transition into the role of a first-time CEO, the opportunities around developing allogeneic, off-the-shelf virus-specific T Cell (VST) therapy candidates, and how she kept her team motivated during COVID.

Length: 33:27       Size: 15MB
Posted in: WoW Podcast

Post a Comment

You must be logged in to post a Comment.